STOCK TITAN

Shareholder in TWST (NASDAQ: TWST) plans sale of 2,200 shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A holder of the issuer’s common stock has filed a Form 144 notice to sell up to 2,200 common shares through Fidelity Brokerage Services LLC on the NASDAQ, with an aggregate market value of $105,394.74, around February 6, 2026.

The 2,200 shares were acquired on February 5, 2026 via restricted stock vesting from the issuer as compensation. Over the prior three months, the same holder sold 7,044 common shares on November 18, 2025 for gross proceeds of $174,479.88.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

How many TWST shares are planned for sale under this Form 144?

The Form 144 covers a planned sale of 2,200 common shares. These shares have an aggregate market value of $105,394.74 and are expected to be sold through Fidelity Brokerage Services LLC on the NASDAQ around February 6, 2026.

How were the TWST shares being sold under Form 144 acquired?

The 2,200 TWST common shares were acquired on February 5, 2026 through restricted stock vesting. They were received directly from the issuer as compensation, rather than purchased for cash in the open market or via another transaction structure.

What prior TWST stock sales has this shareholder reported in the last three months?

During the past three months, the shareholder reported selling 7,044 common shares of TWST on November 18, 2025, generating $174,479.88 in gross proceeds. This sale is listed separately from the newly planned 2,200-share transaction in the disclosure.

Which broker and exchange will handle the planned TWST share sale?

The Form 144 states that the sale will be executed through Fidelity Brokerage Services LLC, located in Smithfield, Rhode Island. The common shares are expected to be sold on the NASDAQ stock market, as indicated in the securities information section.

What type of TWST security is covered by this Form 144 notice?

The notice covers the issuer’s common stock. It specifies that 2,200 units of this common equity class may be sold, and also notes the shares’ acquisition via restricted stock vesting and their planned sale on the NASDAQ through a named broker.
Twist Bioscience

NASDAQ:TWST

TWST Rankings

TWST Latest News

TWST Latest SEC Filings

TWST Stock Data

2.89B
60.29M
1.86%
115.89%
16.96%
Diagnostics & Research
Biological Products, (no Disgnostic Substances)
Link
United States
SOUTH SAN FRANCISCO